PIN60 COST-EFFECTIVENESS OF PEGINTERFERON ALFA-2A VERSUS ENTECAVIR IN THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)75118-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)75118-4/fulltext
Title :
PIN60 COST-EFFECTIVENESS OF PEGINTERFERON ALFA-2A VERSUS ENTECAVIR IN THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)75118-4&doi=10.1016/S1098-3015(10)75118-4
First page :
Section Title :
Open access? :
No
Section Order :
1043